Colleran David bought ANIK
March 9, 2026 · Form 4 insider transaction
Colleran David bought 5,465 shares of Anika Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,465
Price
N/A
Total value
N/A
InsiderColleran David
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 9, 2026
Filing dateMarch 11, 2026
Shares owned after55,019
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.; Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2025 and 800 shares purchased on November 14, 2025.